Chemotherapeutic options for the treatment of human trichomoniasis
- 1 February 2019
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 53 (2) , 116-127
Abstract
No abstract availableKeywords
This publication has 176 references indexed in Scilit:
- Trichomoniasis and HIV interactions: a reviewSexually Transmitted Infections, 2013
- Trichomonas vaginalisAntimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010Emerging Infectious Diseases, 2012
- Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, in pouch TV culture system, and PCRJournal of Global Infectious Diseases, 2012
- Antiprotozoal activity of proton-pump inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- In vitro activity of N-chlorotaurine (NCT) in combination with NH4Cl against Trichomonas vaginalisInternational Journal of Antimicrobial Agents, 2011
- Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and MetronidazoleInfectious Diseases in Obstetrics and Gynecology, 2010
- Trichomoniasis and Other Sexually Transmitted Infections: Results From the 2001–2004 National Health and Nutrition Examination SurveysSexually Transmitted Diseases, 2009
- Efflux-Mediated Antifungal Drug ResistanceClinical Microbiology Reviews, 2009
- Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and TinidazoleAntimicrobial Agents and Chemotherapy, 2006
- In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalisJournal of Antimicrobial Chemotherapy, 2005